The activities of the Plantex plant, which produces complex API, will be transferred to China or India.
The company is hiring employees for its cancer informatics division in Israel.
The US tax reform challenges the attractiveness of Israeli high tech to foreign companies and investors, insists Intel Israel CEO Yaniv Garti.
The competition means higher wages and better conditions for students working in high tech.
Ethosia CEO Eyal Solomon warns that salaries in the sector are a bubble, which might burst because companies will be forced to leave Israel.
Every change in Teva's business is amplified in its share price.
Teva, Israel's universities and the state should join forces to find and develop new drugs, says Prof. Eyal Winter.
Prime Minister Benjamin Netanyahu is believed to prefer tearing up the agreement reached with Israel Electric Corporation workers and pressing for a court ruling limiting their right to strike.
As Teva workers await the axe, one tells "Globes" that he fears he will be shortchanged while outgoing CSO Michael Hayden gets $2.5 million by the end of 2018.
Who really calls the shots at the Israeli carrier, and what time bomb is concealed in its balance sheet, asks Avishai Ovadia.
Having gained 12% against the dollar over the past five years, 2018 might be the year in which the shekel changes direction, argues Meitav Dash chief economist Alex Zabezhinsky.
The Israel Innovation Authority's annual report includes an operational plan for doubling the proportion of high-tech employees in the workforce over the next decade.